GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (FRA:THR) » Definitions » Loans Receivable

ThermoGenesis Holdings (FRA:THR) Loans Receivable : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is ThermoGenesis Holdings Loans Receivable?

ThermoGenesis Holdings's Loans Receivable for the quarter that ended in Mar. 2024 was €0.00 Mil.


ThermoGenesis Holdings Loans Receivable Historical Data

The historical data trend for ThermoGenesis Holdings's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Loans Receivable Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ThermoGenesis Holdings Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


ThermoGenesis Holdings Loans Receivable Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (FRA:THR) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.